ARCHIVES

In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office

This article is from The Cancer Letter archive.

Vol. 16 No. 29 | July 20, 1990

Download PDF Visit The Full Archive

Related Articles

Evidence Too Weak to Link Agent Orange, Cancer, IOM Says

March 22, 2002

Advisers Fume Over Preventions Budget Cut; NIH Probably Did It

May 22, 1992

Roswell Park Researchers Advocate HPV Vaccination For Boys As Well As Girls

May 29, 2009

Clinical Research Needs Payment Mechanism, Kerrey

February 4, 1994

ASCO Calls For New Clinical Study Section, Endorses NCAB Action In Senate Testimony

July 23, 1993

Gene Therapy Experiments Get RDAC Okay

August 10, 1990